Incretins: Turning the Venom into the Antidote
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Insights in Nutrition to Optimize Type 1 Diabetes Therapy.
Cadario F Nutrients. 2024; 16(21).
PMID: 39519472 PMC: 11547730. DOI: 10.3390/nu16213639.
References
1.
Nauck M, Muller T
. Incretin hormones and type 2 diabetes. Diabetologia. 2023; 66(10):1780-1795.
PMC: 10474001.
DOI: 10.1007/s00125-023-05956-x.
View
2.
Eng J, Kleinman W, Singh L, Singh G, Raufman J
. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992; 267(11):7402-5.
View
3.
Tschop M, Nogueiras R, Ahren B
. Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy. Diabetologia. 2023; 66(10):1796-1808.
PMC: 10474213.
DOI: 10.1007/s00125-023-05929-0.
View
4.
Drucker D, Holst J
. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023; 66(10):1765-1779.
DOI: 10.1007/s00125-023-05906-7.
View
5.
Mathieu C, Ahmadzai I
. Incretins beyond type 2 diabetes. Diabetologia. 2023; 66(10):1809-1819.
DOI: 10.1007/s00125-023-05980-x.
View